IPCA Laboratories Limited — Board Meeting, 29-05-2025: Outcome of Board Meeting

Ipca Laboratories has announced a board meeting on the financial results for the quarter and half-year, reporting robust performance. Consolidated net total income rose 15% to Rs. 9,032 Cr, led by a 12% increase in domestic formulations and 4% growth in exports. EBITDA margin expanded to 18.94%, while consolidated net profit before exceptional items jumped 56% to Rs. 993 Cr. Standalone net profit climbed 40% to Rs. 932 Cr. The board has approved a final dividend of Rs. 2 per share and proposed expansion into green energy, pending shareholder nod.